////// Science for a better life Global Breadcrumb Home Investors Bayer AG Euro 48.69 (1.01 %) Creating Value For Our Shareholders WHY INVEST IN BAYER Report Highlights Quarterly Statement Third Quarter 2021 DOWNLOAD TOOL Investment Case BAYER GROUP A Global Leader in Health & Nutrition READ MORE CROP SCIENCE Shaping the Future of Agriculture READ MORE Event Highlights November 15, 2021 Finerenone Investor-Webinar November 2021 READ MORE November 9, 2021 Investor Conference Call Q3 2021 Results READ MORE October 19, 2021 Crop Science Investor Webinar 2021 READ MORE August 5, 2021 Investor Conference Call Q2 2021 Results READ MORE VIEW ALL EVENTS News from Bayer November 15, 2021 Not intended for U.S. and UK Media Bayer extends clinical development program for finerenone with Phase III study in children and adolescents with chronic kidney disease READ MORE November 11, 2021 Not intended for U.S. and UK Media New Phase III study to investigate expanded use of vericiguat in patients with chronic heart failure with reduced ejection fraction READ MORE November 10, 2021 Not intended for U.S. and UK Media Bayer Submits Aflibercept for regulatory approval in the EU and Japan for Retinopathy of Prematurity in premature babies READ MORE NEWS OVERVIEW Sustainability & Governance Our Commitment to Sustainability LEARN MORE Discover More Investor Resources DIVIDENDS Returning Value to Shareowners LEARN MORE DEBT Detailed Insight into Debt & Fixed Income LEARN MORE STOCK CHARTS Discover Our Interactive Stock Charts LEARN MORE CORPORATE GOVERNANCE Managing and Supervising an Enterprise LEARN MORE CONTACT IR TEAM Get In Touch With Us LEARN MORE NEWSLETTER Subscribe To Our Latest Investor News LEARN MORE USES AND SAFETY RECORD Let’s Talk About Glyphosate LEARN MORE LEARN ABOUT THE LITIGATION Glyphosate Litigation Facts LEARN MORE Last Updated: Tuesday, November 23, 2021 Our Business Pharmaceuticals Consumer Health Crop Science Our Products Bayer Worldwide Magazines & Reports News & Stories Annual Report Quarterly Report More Publications Stay Tuned Job Postings Latest News Newsletter Bayer Share Price Get in Touch Do you have any queries or comments? GLOBAL FORM REPORT A SIDE EFFECT Follow Us Copyright © Bayer AG Conditions of Use Privacy Statement Cookie Settings Imprint Sitemap Usage of Cookies We would like to use optional cookies to better understand your use of this website, to improve our website and to share information with our advertising partners. Detailed information about the use of strictly necessary cookies, which are essential to browse this website, and optional cookies, which you can reject or accept below, and how you can manage or withdraw your consent at any time can be found in our Privacy Statement. COOKIE SETTINGS REJECT COOKIES ACCEPT COOKIES